RPI Scientists Developing Gene Editing Technology to Treat Alzheimer's

A new grant from National Institutes of Health will kickstart project
This year, Rensselaer Polytechnic Institute researchers will begin work on a radically new approach to treating and preventing genetic diseases such as Alzheimer’s.It’s thanks to a grant from the National Institutes of Health’s TARGETED Challenge, which funds scientific research on ways to deliver gene editing tools directly to cells in the human body.